The Probiotic Preparation, VSL#3 Induces Remission in Patients With Mild-to- Moderately Active Ulcerative Colitis  Ajit Sood, Vandana Midha, Govind K. Makharia, Vineet Ahuja, Dinesh Singal, Pooja Goswami, Rakesh K. Tandon  Clinical Gastroenterology and Hepatology  Volume 7, Issue 11, Pages 1202-1209.e1 (November 2009) DOI: 10.1016/j.cgh.2009.07.016 Copyright © 2009 AGA Institute Terms and Conditions

Figure 1 Bar diagrams showing the (A) number of patients with a decrease in UCDAI score from greater than 50% from baseline at week 6, (B) number of patients with a decrease in total UCDAI of at least 3 points at week 12, (C) number of patients who attained remission (UCDAI < 3) at week 12, and (D) number of patients achieving mucosal healing (mucosal assessment score of 0 at week 12). Clinical Gastroenterology and Hepatology 2009 7, 1202-1209.e1DOI: (10.1016/j.cgh.2009.07.016) Copyright © 2009 AGA Institute Terms and Conditions

Figure 2 Line diagrams showing the decrease in (A) stool frequency score, (B) rectal bleeding score, (C) mucosal appearance score, (D) physician's global assessment score, and (E) UC disease activity score at baseline, week 6, and week 12 in the VSL#3 and placebo groups. Clinical Gastroenterology and Hepatology 2009 7, 1202-1209.e1DOI: (10.1016/j.cgh.2009.07.016) Copyright © 2009 AGA Institute Terms and Conditions

Supplementary Figure 1 Flow of patients in the VSL#3 and placebo groups. Clinical Gastroenterology and Hepatology 2009 7, 1202-1209.e1DOI: (10.1016/j.cgh.2009.07.016) Copyright © 2009 AGA Institute Terms and Conditions